Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Greg Dollarhyde
AddedFeb 15, 2024
UpdatedJun 28, 2026
Greg Dollarhyde

Greg Dollarhyde

Board Member, ExThera Medical

Greg Dollarhyde's Career

ExThera Medical
ExThera Medical

Martinez, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Greg Dollarhyde's Career

ExThera Medical
ExThera Medical
Series A$61.3M362008Martinez, CA, US
Board Member· Board

Leadership at ExThera Medical

Robert WardRobert WardCEO
John W. FeikJohn W. FeikBoard Member
John T PrestonJohn T PrestonBoard Member
Bob WardBob WardFounder
Prof Dr Michael E PorterProf Dr Michael E PorterBoard Member

Similar to ExThera Medical

Aethlon MedicalAethlon MedicalSan Diego, CA, USMedical Devicesest. 1999Aethlon MedicalSan Diego, CA, US · est. 1999

Aethlon Medical, a San Diego-based company, develops innovative medical devices targeting disease-promoting particles.

Public · $30.1M15
TheraB MedicalTheraB MedicalLansing, MI, USMedical Devicesest. 2014TheraB MedicalLansing, MI, US · est. 2014

TheraB Medical: Holistic jaundice treatment devices keeping babies with their mothers.

Pre-Seed · $1.2M30
Path EXPath EXNashville, TN, USMedical Devicesest. 2016Path EXNashville, TN, US · est. 2016

PATH EX: Pioneering sepsis treatment through proprietary technology that selectively captures and removes bacteria from blood.

Seed · $4.8M3
EmbolxEmbolxSunnyvale, CA, USMedical Devicesest. 2013EmbolxSunnyvale, CA, US · est. 2013

Embolx: A medical device startup innovating in cancer treatment with novel embolization microcatheters.

Seed · $2.5M12

Greg Dollarhyde's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Greg Dollarhyde

Craig A T JonesCraig A T JonesBoard Member · National Venture Capital AssociationStephanie DavisStephanie DavisBoard Member · AthenexDavid SaltzmanDavid SaltzmanBoard Member · Mode MediaPaul BartlettPaul BartlettBoard Member · IntransaemadeddinemadeddinBoard Member · CargillJohn RowanJohn RowanBoard Member · Independence Resources Management